-+ 0.00%
-+ 0.00%
-+ 0.00%

Benchmark Maintains Buy on BlueLinx Hldgs, Lowers Price Target to $75

Benzinga·02/27/2026 17:32:52
Listen to the news
Benchmark analyst Reuben Garner maintains BlueLinx Hldgs (NYSE:BXC) with a Buy and lowers the price target from $83 to $75.